COHERENT CORP - COHR 6 07/01/23 (IIVI) Fundamental Analysis & Valuation

NYSE:IIVIUS19247G2066

Current stock price

227.08 USD
+11.82 (+5.49%)
Last:

This IIVI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. IIVI Profitability Analysis

1.1 Basic Checks

  • In the past year IIVI was profitable.
  • IIVI had a positive operating cash flow in the past year.
IIVI Yearly Net Income VS EBIT VS OCF VS FCFIIVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 200M 400M

1.2 Ratios

  • IIVI has negative profitability rations, so we won't be analyzing them here.
  • IIVI has a Return On Invested Capital (1.87%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for IIVI is below the industry average of 8.33%.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 1.87%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.47%
ROIC(5y)6.09%
IIVI Yearly ROA, ROE, ROICIIVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 2 -2 4 6 8 10

1.3 Margins

  • In the last couple of years the Profit Margin of IIVI has declined.
  • IIVI's Operating Margin of 6.00% is fine compared to the rest of the industry. IIVI outperforms 71.32% of its industry peers.
  • In the last couple of years the Operating Margin of IIVI has grown nicely.
  • With a decent Gross Margin value of 33.06%, IIVI is doing good in the industry, outperforming 60.47% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IIVI has remained more or less at the same level.
Industry RankSector Rank
OM 6%
PM (TTM) N/A
GM 33.06%
OM growth 3Y0.85%
OM growth 5Y1.69%
PM growth 3Y-13.99%
PM growth 5Y-12.53%
GM growth 3Y-0.09%
GM growth 5Y-0.92%
IIVI Yearly Profit, Operating, Gross MarginsIIVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 20 30

4

2. IIVI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IIVI is destroying value.
  • Compared to 1 year ago, IIVI has more shares outstanding
  • IIVI has a worse debt/assets ratio than last year.
IIVI Yearly Shares OutstandingIIVI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
IIVI Yearly Total Debt VS Total AssetsIIVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.2 Solvency

  • IIVI has an Altman-Z score of 3.57. This indicates that IIVI is financially healthy and has little risk of bankruptcy at the moment.
  • IIVI's Altman-Z score of 3.57 is fine compared to the rest of the industry. IIVI outperforms 60.47% of its industry peers.
  • IIVI has a debt to FCF ratio of 34.44. This is a negative value and a sign of low solvency as IIVI would need 34.44 years to pay back of all of its debts.
  • IIVI has a Debt to FCF ratio (34.44) which is comparable to the rest of the industry.
  • IIVI has a Debt/Equity ratio of 0.58. This is a neutral value indicating IIVI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of IIVI (0.58) is worse than 83.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 34.44
Altman-Z 3.57
ROIC/WACC0.2
WACC9.56%
IIVI Yearly LT Debt VS Equity VS FCFIIVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 3.08 indicates that IIVI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.08, IIVI is in the better half of the industry, outperforming 62.02% of the companies in the same industry.
  • A Quick Ratio of 1.82 indicates that IIVI should not have too much problems paying its short term obligations.
  • IIVI has a Quick ratio (1.82) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 1.82
IIVI Yearly Current Assets VS Current LiabilitesIIVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B

7

3. IIVI Growth Analysis

3.1 Past

  • IIVI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.93%.
  • Measured over the past years, IIVI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.68% on average per year.
  • Looking at the last year, IIVI shows a very strong growth in Revenue. The Revenue has grown by 49.56%.
  • Measured over the past years, IIVI shows a very strong growth in Revenue. The Revenue has been growing by 27.82% on average per year.
EPS 1Y (TTM)-1.93%
EPS 3Y13.27%
EPS 5Y18.68%
EPS Q2Q%-38.95%
Revenue 1Y (TTM)49.56%
Revenue growth 3Y34.52%
Revenue growth 5Y27.82%
Sales Q2Q%49.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.68% on average over the next years. This is quite good.
  • IIVI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.99% yearly.
EPS Next Y2.69%
EPS Next 2Y11.05%
EPS Next 3Y15.16%
EPS Next 5Y11.68%
Revenue Next Year65.72%
Revenue Next 2Y33.82%
Revenue Next 3Y25.01%
Revenue Next 5Y17.99%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IIVI Yearly Revenue VS EstimatesIIVI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
IIVI Yearly EPS VS EstimatesIIVI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

2

4. IIVI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 63.97, the valuation of IIVI can be described as expensive.
  • IIVI's Price/Earnings ratio is in line with the industry average.
  • IIVI is valuated expensively when we compare the Price/Earnings ratio to 24.75, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 49.50 indicates a quite expensive valuation of IIVI.
  • IIVI's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, IIVI is valued quite expensively.
Industry RankSector Rank
PE 63.97
Fwd PE 49.5
IIVI Price Earnings VS Forward Price EarningsIIVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IIVI is on the same level as its industry peers.
  • 60.47% of the companies in the same industry are more expensive than IIVI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 246.31
EV/EBITDA 41.79
IIVI Per share dataIIVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IIVI does not grow enough to justify the current Price/Earnings ratio.
  • IIVI's earnings are expected to grow with 15.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)23.79
PEG (5Y)3.42
EPS Next 2Y11.05%
EPS Next 3Y15.16%

0

5. IIVI Dividend Analysis

5.1 Amount

  • IIVI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IIVI Fundamentals: All Metrics, Ratios and Statistics

COHERENT CORP - COHR 6 07/01/23

NYSE:IIVI (6/30/2023, 8:21:10 PM)

227.08

+11.82 (+5.49%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-10
Earnings (Next)08-22
Inst Owners0.01%
Inst Owner Change-14.64%
Ins Owners0.76%
Ins Owner Change0%
Market Cap31.65B
Revenue(TTM)4.84B
Net Income(TTM)-162.49M
Analysts74.55
Price Target203.06 (-10.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-16.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.25%
Min EPS beat(2)-30.58%
Max EPS beat(2)0.07%
EPS beat(4)3
Avg EPS beat(4)-1.48%
Min EPS beat(4)-30.58%
Max EPS beat(4)22.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.63%
Min Revenue beat(2)-9.14%
Max Revenue beat(2)-2.12%
Revenue beat(4)1
Avg Revenue beat(4)-3.03%
Min Revenue beat(4)-9.14%
Max Revenue beat(4)1.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-58.41%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 63.97
Fwd PE 49.5
P/S 6.54
P/FCF 246.31
P/OCF 53.66
P/B 4.25
P/tB N/A
EV/EBITDA 41.79
EPS(TTM)3.55
EY1.56%
EPS(NY)4.59
Fwd EY2.02%
FCF(TTM)0.92
FCFY0.41%
OCF(TTM)4.23
OCFY1.86%
SpS34.74
BVpS53.46
TBVpS-7.23
PEG (NY)23.79
PEG (5Y)3.42
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 1.87%
ROICexc 2.01%
ROICexgc 6.67%
OM 6%
PM (TTM) N/A
GM 33.06%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.47%
ROIC(5y)6.09%
ROICexc(3y)6.56%
ROICexc(5y)7.9%
ROICexgc(3y)12.66%
ROICexgc(5y)13.34%
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y7.05%
ROICexgc growth 5Y2.62%
ROICexc growth 3Y-2.61%
ROICexc growth 5Y-1.07%
OM growth 3Y0.85%
OM growth 5Y1.69%
PM growth 3Y-13.99%
PM growth 5Y-12.53%
GM growth 3Y-0.09%
GM growth 5Y-0.92%
F-Score3
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 34.44
Debt/EBITDA 5.26
Cap/Depr 83.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 1.82
Altman-Z 3.57
F-Score3
WACC9.56%
ROIC/WACC0.2
Cap/Depr(3y)75.81%
Cap/Depr(5y)113.17%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.93%
EPS 3Y13.27%
EPS 5Y18.68%
EPS Q2Q%-38.95%
EPS Next Y2.69%
EPS Next 2Y11.05%
EPS Next 3Y15.16%
EPS Next 5Y11.68%
Revenue 1Y (TTM)49.56%
Revenue growth 3Y34.52%
Revenue growth 5Y27.82%
Sales Q2Q%49.84%
Revenue Next Year65.72%
Revenue Next 2Y33.82%
Revenue Next 3Y25.01%
Revenue Next 5Y17.99%
EBIT growth 1Y-35.57%
EBIT growth 3Y35.66%
EBIT growth 5Y29.99%
EBIT Next Year120.78%
EBIT Next 3Y40.91%
EBIT Next 5Y25.33%
FCF growth 1Y-73.55%
FCF growth 3Y33.72%
FCF growth 5YN/A
OCF growth 1Y-5.44%
OCF growth 3Y32.29%
OCF growth 5Y28.36%

COHERENT CORP - COHR 6 07/01/23 / IIVI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COHERENT CORP - COHR 6 07/01/23 (IIVI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IIVI.


Can you provide the valuation status for COHERENT CORP - COHR 6 07/01/23?

ChartMill assigns a valuation rating of 0 / 10 to COHERENT CORP - COHR 6 07/01/23 (IIVI). This can be considered as Overvalued.


How profitable is COHERENT CORP - COHR 6 07/01/23 (IIVI) stock?

COHERENT CORP - COHR 6 07/01/23 (IIVI) has a profitability rating of 1 / 10.


What are the PE and PB ratios of COHERENT CORP - COHR 6 07/01/23 (IIVI) stock?

The Price/Earnings (PE) ratio for COHERENT CORP - COHR 6 07/01/23 (IIVI) is 63.97 and the Price/Book (PB) ratio is 4.25.


Is the dividend of COHERENT CORP - COHR 6 07/01/23 sustainable?

The dividend rating of COHERENT CORP - COHR 6 07/01/23 (IIVI) is 0 / 10 and the dividend payout ratio is -16.99%.